Accessibility Menu
 
Thc Farmaceuticals logo

Thc Farmaceuticals

(OTC) CBDG

Current Price$0.02
Market Cap$380,800
Since IPO (2014)-99%
5 Year-90%
1 Year+56%
1 Month+0%

Thc Farmaceuticals Financials at a Glance

Market Cap

$380,800

Revenue (TTM)

$15.03K

Net Income (TTM)

$48.13K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

44.20 (High)

Price

$0.02

Volume

7,326

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.10

CBDG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Thc Farmaceuticals

Industry

Commercial Services and Supplies

Employees

2

CEO

Mike Gravel

Headquarters

Scottsdale, AZ 85253, US

CBDG Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$380.80K

Shares Outstanding

18.13M

Volume

7.33K

Short Interest

0.00%

Avg. Volume

414.177

Financials (TTM)

Gross Profit

$4.95K

Operating Income

$29.95K

EBITDA

$25.00K

Operating Cash Flow

$635.54K

Capital Expenditure

$3.00

Free Cash Flow

$635.54K

Cash & ST Invst.

$1.71K

Total Debt

$141.52K

Thc Farmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$952.00

-115.1%

Gross Margin

0.00%

N/A

Market Cap

$380.80K

N/A

Market Cap/Employee

$190.40K

N/A

Employees

2

N/A

Net Income

$3.16K

+99.3%

EBITDA

$5.37K

+99.4%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Net Cash

$379.43K

+58.5%

Accounts Receivable

$636.22K

+2.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$386.30K

-57.9%

Return on Assets

-0.55%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

$4.48K

+90.4%

Operating Cash Flow

$4.48K

+90.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ENMIDH Enchantment Inc.
$0.00+0.00%
RASPActavia Life Sciences, Inc.
$0.00+0.00%
VIRXViracta Therapeutics, Inc.
$0.01+0.00%
IPIXInnovation Pharmaceuticals Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About CBDG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.